For many people living with rheumatoid arthritis, modern medicines have changed their lives.
Treatments that target inflammation can reduce joint damage, ease pain, and help patients stay active for longer.
Yet there remains a group of patients who continue to suffer from pain, tiredness, and poor quality of life even after receiving the best available treatments.
A new analysis by researchers at Semmelweis University suggests that the answer may not always lie in the joints themselves.
Instead, the researchers believe that factors such as depression, poor sleep, obesity, smoking, and chronic pain may be quietly driving symptoms that appear to be caused by arthritis.
The research was published in Nature Reviews Rheumatology and The Lancet Rheumatology. The studies propose a new way of thinking about difficult-to-treat rheumatoid arthritis and offer doctors a framework for identifying what may really be causing ongoing symptoms.
Rheumatoid arthritis is a chronic condition in which the immune system attacks the lining of the joints. This leads to inflammation, swelling, pain, and stiffness. If left untreated, it can cause permanent joint damage.
Advances in treatment over the past two decades have dramatically improved outcomes. Many patients can now achieve remission, a state in which disease activity becomes very low or disappears.
Despite these advances, between 6% and 28% of patients fall into the difficult-to-treat category. These patients continue to experience symptoms despite receiving multiple treatments. Traditionally, doctors may assume that persistent symptoms mean inflammation is still active and that stronger medication is needed.
The Semmelweis University team argues that this assumption is not always correct. They found evidence that other health conditions can strongly influence how patients feel. These conditions may exist alongside rheumatoid arthritis and may continue causing symptoms even when inflammation is controlled.
One example is sleep. Poor sleep can increase sensitivity to pain and reduce the body’s ability to recover. A person who sleeps badly may wake up feeling sore, tired, and unable to function well. Depression can have a similar effect.
It can reduce energy, lower motivation, and increase the perception of pain. Obesity may make movement more difficult and contribute to fatigue. Smoking is linked to poorer health outcomes and may worsen overall wellbeing.
These problems often do not occur alone. A patient with chronic pain may become less active. Reduced activity can contribute to weight gain. Extra weight may worsen sleep quality. Poor sleep can worsen mood. Depression can increase the feeling of pain. Eventually, several problems become connected in a self-reinforcing cycle.
The researchers believe that understanding these connections is essential. They suggest that doctors should use treatment monitoring not only to guide medication decisions but also to identify situations where symptoms and inflammation no longer match.
Dr. György Nagy explained that if inflammation markers improve but symptoms remain severe, doctors should look beyond the immune system. Instead of immediately increasing medication, healthcare teams should consider whether depression, sleep disorders, obesity, chronic pain syndromes, or other conditions may be responsible.
This approach may help prevent unnecessary treatment changes and ensure patients receive support for the problems that are truly affecting them. It may also encourage a more personalized style of care that considers physical and emotional health together.
The impact of this work has already extended far beyond Hungary. The researchers’ publications have been cited more than a thousand times and have helped shape international definitions of difficult-to-treat disease.
Their ideas are now being applied not only in rheumatoid arthritis but also in other chronic illnesses where symptoms may have multiple causes.
The team is now exploring how artificial intelligence could help improve patient care even further. By examining large collections of patient information, AI systems may be able to identify hidden patterns that humans might miss.
This could allow doctors to divide patients into smaller groups based on their symptoms, risk factors, and treatment responses. Such an approach could eventually lead to highly personalized treatment plans.
The broader lesson from this research is that successful treatment is about more than controlling a disease. Patients are affected by mental health, sleep habits, lifestyle choices, and many other factors that interact with one another. Addressing these factors may be just as important as treating inflammation itself.
One major strength of the research is its holistic view of rheumatoid arthritis. Instead of focusing on a single biological process, it recognizes the complexity of real-world patient experiences. A limitation is that the proposed treatment model still needs to be tested in larger studies before it can become standard practice.
Even so, the findings provide a valuable reminder that persistent symptoms may have many causes, and understanding those causes could lead to better care and better lives for patients.
